{"entity":{"type":"insider","cik":"0001524338","url":"/insider/0001524338","json_url":"/insider/0001524338.json","name":"LARANJEIRA CHARLES ANTHONY","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":8,"first":"2013-02-20","last":"2022-06-08","span_basis":"filed_date"},"name_variants":[{"name":"LARANJEIRA CHARLES ANTHONY","source":"filing","n_filings":8,"first_seen":"2013-02-20","last_seen":"2022-06-08"}],"transactions":[{"id":6304726,"accession":"0001209191-22-035228","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-035228","line_url":"/filing/0001209191-22-035228","is_derivative":false,"issuer_cik":"0001396814","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001396814","owner_cik":"0001524338","owner_name":"LARANJEIRA CHARLES ANTHONY","owner_display_name":"LARANJEIRA CHARLES ANTHONY","owner_url":"/insider/0001524338","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4937.0,"shares_display":"4,937","price_per_share":59.8168462629127,"price_display":"59.82","price_state":"stated","total_value":295315.77,"total_display":"295,315.77","total_whole":"295,316","shares_owned_after":28268.0,"shares_owned_after_display":"28,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-08","filed_date":"2022-06-08","scope":"insider","n_lines":4},{"id":6304708,"accession":"0001209191-22-035228","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-035228","line_url":"/filing/0001209191-22-035228#line-1","is_derivative":false,"issuer_cik":"0001396814","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001396814","owner_cik":"0001524338","owner_name":"LARANJEIRA CHARLES ANTHONY","owner_display_name":"LARANJEIRA CHARLES ANTHONY","owner_url":"/insider/0001524338","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2813.0,"shares_display":"2,813","price_per_share":61.374,"price_display":"61.37","price_state":"stated","total_value":172645.062,"total_display":"172,645.06","total_whole":"172,645","shares_owned_after":30789.0,"shares_owned_after_display":"30,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-08","scope":"insider"},{"id":5498067,"accession":"0001209191-21-038881","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-038881","line_url":"/filing/0001209191-21-038881#line-1","is_derivative":false,"issuer_cik":"0001396814","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001396814","owner_cik":"0001524338","owner_name":"LARANJEIRA CHARLES ANTHONY","owner_display_name":"LARANJEIRA CHARLES ANTHONY","owner_url":"/insider/0001524338","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2117.0,"shares_display":"2,117","price_per_share":61.037,"price_display":"61.04","price_state":"stated","total_value":129215.329,"total_display":"129,215.33","total_whole":"129,215","shares_owned_after":18681.0,"shares_owned_after_display":"18,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-04","filed_date":"2021-06-08","scope":"insider"},{"id":2900892,"accession":"0001209191-20-045200","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-045200","line_url":"/filing/0001209191-20-045200#line-2","is_derivative":false,"issuer_cik":"0001396814","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001396814","owner_cik":"0001524338","owner_name":"LARANJEIRA CHARLES ANTHONY","owner_display_name":"LARANJEIRA CHARLES ANTHONY","owner_url":"/insider/0001524338","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":52.68,"price_display":"52.68","price_state":"stated","total_value":131700.0,"total_display":"131,700.00","total_whole":"131,700","shares_owned_after":20796.0,"shares_owned_after_display":"20,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-05","scope":"insider"},{"id":2180759,"accession":"0001209191-20-039976","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-039976","line_url":"/filing/0001209191-20-039976","is_derivative":false,"issuer_cik":"0001396814","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001396814","owner_cik":"0001524338","owner_name":"LARANJEIRA CHARLES ANTHONY","owner_display_name":"LARANJEIRA CHARLES ANTHONY","owner_url":"/insider/0001524338","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60101.0,"shares_display":"60,101","price_per_share":50.270617959767726,"price_display":"50.27","price_state":"stated","total_value":3021314.41,"total_display":"3,021,314.41","total_whole":"3,021,314","shares_owned_after":28887.0,"shares_owned_after_display":"28,887","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-29","filed_date":"2020-07-01","scope":"insider","n_lines":3},{"id":2880840,"accession":"0001209191-20-035171","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-035171","line_url":"/filing/0001209191-20-035171#line-1","is_derivative":false,"issuer_cik":"0001396814","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001396814","owner_cik":"0001524338","owner_name":"LARANJEIRA CHARLES ANTHONY","owner_display_name":"LARANJEIRA CHARLES ANTHONY","owner_url":"/insider/0001524338","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":863.0,"shares_display":"863","price_per_share":46.331,"price_display":"46.33","price_state":"stated","total_value":39983.653,"total_display":"39,983.65","total_whole":"39,984","shares_owned_after":10101.0,"shares_owned_after_display":"10,101","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-04","filed_date":"2020-06-08","scope":"insider"},{"id":8618622,"accession":"0001209191-19-035098","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-035098","line_url":"/filing/0001209191-19-035098#line-1","is_derivative":false,"issuer_cik":"0001396814","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001396814","owner_cik":"0001524338","owner_name":"LARANJEIRA CHARLES ANTHONY","owner_display_name":"LARANJEIRA CHARLES ANTHONY","owner_url":"/insider/0001524338","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":430.0,"shares_display":"430","price_per_share":42.91,"price_display":"42.91","price_state":"stated","total_value":18451.3,"total_display":"18,451.30","total_whole":"18,451","shares_owned_after":5367.0,"shares_owned_after_display":"5,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-04","filed_date":"2019-06-06","scope":"insider"},{"id":5053958,"accession":"0001127602-13-017834","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-13-017834","line_url":"/filing/0001127602-13-017834","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001524338","owner_name":"LARANJEIRA CHARLES ANTHONY","owner_display_name":"LARANJEIRA CHARLES ANTHONY","owner_url":"/insider/0001524338","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":51.42857142857143,"price_display":"51.43","price_state":"stated","total_value":720000.0,"total_display":"720,000.00","total_whole":"720,000","shares_owned_after":5257.0,"shares_owned_after_display":"5,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-20","filed_date":"2013-05-22","scope":"insider","n_lines":2},{"id":4912474,"accession":"0001127602-13-006941","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-006941","line_url":"/filing/0001127602-13-006941#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001524338","owner_name":"LARANJEIRA CHARLES ANTHONY","owner_display_name":"LARANJEIRA CHARLES ANTHONY","owner_url":"/insider/0001524338","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":384.0,"shares_display":"384","price_per_share":41.4003,"price_display":"41.40","price_state":"stated","total_value":15897.7152,"total_display":"15,897.72","total_whole":"15,898","shares_owned_after":1257.0,"shares_owned_after_display":"1,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-19","filed_date":"2013-02-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001396814","name":"Pacira BioSciences, Inc.","url":"/issuer/0001396814","role":"Officer (Chief Technical Officer)","n_filings":6,"first_seen":"2019-06-06","last_seen":"2022-06-08"},{"type":"issuer","type_label":"ISSUER","cik":"0000912183","name":"CUBIST PHARMACEUTICALS INC","url":"/issuer/0000912183","role":"Officer (SVP, Technical Operations)","n_filings":2,"first_seen":"2013-02-20","last_seen":"2013-05-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001524338","retrieved_at":"2026-08-25T05:49:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}